Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards
Sauzet O, Dyck JA, Cornelius V (2024)
Drug Safety .
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
s40264-024-01460-2.pdf
705.77 KB
Autor*in
Sauzet, OdileUniBi;
Dyck, Julia AlexandraUniBi;
Cornelius, Victoria
Einrichtung
Abstract / Bemerkung
BACKGROUND AND OBJECTIVES: Statistical methods for signal detection of adverse drug reactions (ADRs) in electronic health records (EHRs) need information about optimal significance levels and sample sizes to achieve sufficient power. Sauzet and Cornelius proposed tests for signal detection based on the hazard functions of Weibull type distributions (WSP tests) which use the time-to-event information available in EHRs. Optimal significance levels and sample sizes for the application of the WPS tests are derived.; METHOD: A simulation study was performed with a range of scenarios for sample size, rate of event due (ADRs), and not due to the drug and random time to ADR occurrence. Based on the area under the curve of the receiver operating characteristic graph, we obtain optimal significance levels of the different WSP tests for the implementation in a hypothesis free signal detection setting and approximate sample sizes required to reach a power of 80% or 90%.; RESULTS: The dWSP-pPWSP (combination of double WSP and power WSP) test with a significance level of 0.004 was recommended. Sample sizes needed for a power of 80% were found to start at 60 events for an ADR rate equal to the background rate of 0.1. The number of events required for a background rate of 0.05 and an ADR rate equal to a 20% increase of the background rate was 900.; CONCLUSION: Based on this study, it is recommended to use the dWSP-pWSP test combination for signal detection with a significance level of 0.004 when the same test is applied to all adverse events not depending on rates. © 2024. The Author(s).
Erscheinungsjahr
2024
Zeitschriftentitel
Drug Safety
Urheberrecht / Lizenzen
eISSN
1179-1942
Finanzierungs-Informationen
Open-Access-Publikationskosten wurden durch die Universität Bielefeld im Rahmen des DEAL-Vertrags gefördert.
Page URI
https://pub.uni-bielefeld.de/record/2991311
Zitieren
Sauzet O, Dyck JA, Cornelius V. Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards. Drug Safety . 2024.
Sauzet, O., Dyck, J. A., & Cornelius, V. (2024). Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards. Drug Safety . https://doi.org/10.1007/s40264-024-01460-2
Sauzet, Odile, Dyck, Julia Alexandra, and Cornelius, Victoria. 2024. “Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards”. Drug Safety .
Sauzet, O., Dyck, J. A., and Cornelius, V. (2024). Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards. Drug Safety .
Sauzet, O., Dyck, J.A., & Cornelius, V., 2024. Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards. Drug Safety .
O. Sauzet, J.A. Dyck, and V. Cornelius, “Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards”, Drug Safety , 2024.
Sauzet, O., Dyck, J.A., Cornelius, V.: Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards. Drug Safety . (2024).
Sauzet, Odile, Dyck, Julia Alexandra, and Cornelius, Victoria. “Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards”. Drug Safety (2024).
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Name
s40264-024-01460-2.pdf
705.77 KB
Access Level
Open Access
Zuletzt Hochgeladen
2025-11-13T10:25:51Z
MD5 Prüfsumme
64f117b448d115db59cfb145f23546d6
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 38982034
PubMed | Europe PMC
Suchen in
